Compound ID | 1265
Class: 2-trifluoroacetonylbenzoxazole ligand
Spectrum of activity: | Gram-positive |
Details of activity: | Methicillin resistant S. aureus strains. |
Institute where first reported: | Department of Medical Microbiology and Immunobiology, University of Szeged - Faculty of Medicine, Szeged, Hungary, Faculty of Pharmaceutical Sciences, Matsuyama University, Matsuyama-shi, Japan |
Year first mentioned: | 2019 |
Highest developmental phase: | Preclinical |
Development status: | Active |